Adipotide FTPP 2mg

What is Adipotide Peptide (FTPP)?

Adipotide peptide is a synthetic peptide molecule that was developed for the purpose of reducing body fat by inducing programmed cell death (apoptosis) of fat cells, also known as adipocytes. This peptide is composed of 132 amino acids and has a molecular weight of 2.3 kDa.

Adipotide works by targeting and binding to specific receptors on the surface of adipocytes, called ANXA2 and prohibitin. Once bound, adipotide causes disruption of the blood supply to adipocytes, leading to apoptosis and ultimately, the reduction of fat tissue. Adipotide has been shown to be highly selective for fat cells, without affecting other types of cells.

Studies on animal models have demonstrated that treatment with adipotide can result in a significant reduction in body weight and fat mass, as well as improvements in metabolic parameters such as insulin sensitivity and glucose tolerance. Adipotide has also been investigated as a potential treatment for obesity-related conditions such as type 2 diabetes and non-alcoholic fatty liver disease.

Adipotide is currently not approved for use in humans and has not undergone extensive clinical trials. It is a research peptide and is primarily used in pre-clinical studies to investigate its potential as a therapeutic agent for obesity and related conditions. The potential side effects and long-term safety of adipotide in humans are not yet fully understood and require further research.

Studies of adipotide in weight loss and obesity-related metabolic conditions.

Adipotide is a peptide compound that is currently being studied for its potential to reduce body fat and treat obesity-related metabolic conditions. The peptide works by inducing apoptosis (programmed cell death) in adipocytes, leading to a reduction in fat mass.

Animal studies have shown promising results for adipotide in terms of weight loss and improvements in metabolic parameters. In one study, obese rhesus monkeys were treated with adipotide for 28 days, resulting in an average weight loss of 11% and a significant decrease in abdominal circumference. The treated monkeys also showed improvements in glucose tolerance and insulin sensitivity.

Other studies have investigated the potential of adipotide to treat conditions such as type 2 diabetes and non-alcoholic fatty liver disease. In a rat model of type 2 diabetes, treatment with adipotide led to a reduction in body weight, improved insulin sensitivity, and decreased liver fat accumulation. In another study on mice with non-alcoholic fatty liver disease, adipotide treatment resulted in a decrease in liver fat content and improved liver function.

Buy Adipotide online from GenX Peptides.

We offer the highest grade and purity of adipotide for sale at a competitive price in the USA. For best results buy adipotide peptides of the highest quality from GenX Peptides.

For more information on Adipotide FTPP peptide please visit Wikipedia.

Products on the website are not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and are not intended to affect the structure or any function of the body. The use of our products are for only research/laboratory purposes.